Literature DB >> 18188592

Consistent numerical chromosome aberrations in thecofibromas of the ovary.

Francesca Micci1, Lisbeth Haugom, Vera M Abeler, Claes G Tropé, Håvard E Danielsen, Sverre Heim.   

Abstract

Sex cord-stromal tumors of the ovary comprise 8% of all ovarian neoplasms. Because they consist of cells that resemble embryonic sex cord and/or specialized ovarian stroma cells, their cytologic and histologic features can be viewed as reflecting a continuum from fibromas to thecomas with thecofibromas in between. Existing cytogenetic knowledge about ovarian thecomas-thecofibromas-fibromas is restricted to 44 cases with chromosomal abnormalities. The most common aberration has been trisomy 12, identified either by karyotyping or using fluorescence in situ hybridization (FISH). We wanted to obtain more information about the genomic composition of these tumors, and, therefore, examined 29 new thecoma-thecofibroma-fibroma tumors of the ovary using karyotyping, comparative genomic hybridization, interphase FISH, and DNA ploidy analysis. We detected aneuploidy in 21 tumors. Trisomy and/or tetrasomy 12 was the most common chromosomal aberration, found in 15 tumors (71.5% of the aneuploid tumors or 51.5% of all analyzed tumors), followed by trisomy for chromosomes 10, 18, 4, and 9. Some monosomies (for chromosomes 4, 9, 10, and 18) were also identified, either as the sole change or in combination with trisomies. The nonrandom occurrence of these aneuploidies in these benign tumors strongly indicates that they play a major pathogenetic role, but how trisomies and other aneuploidies contribute to tumorigenesis remains unknown.

Entities:  

Mesh:

Year:  2008        PMID: 18188592     DOI: 10.1007/s00428-007-0561-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Trisomy 12 and 4 in a thecoma of the ovary.

Authors:  K Mrózek; J Limon; J Debniak; J Emerich
Journal:  Gynecol Oncol       Date:  1992-04       Impact factor: 5.482

2.  Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia.

Authors:  J A Garcìa-Marco; C M Price; J Ellis; M Morey; E Matutes; D Lens; S Colman; D Catovsky
Journal:  Leukemia       Date:  1996-11       Impact factor: 11.528

3.  Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.

Authors:  M Nilbert; S Heim; N Mandahl; U M Flodérus; H Willén; F Mitelman
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

4.  FISH analysis of interphase nuclei extracted from paraffin-embedded tissue.

Authors:  T Liehr; H Grehl; B Rautenstrauss
Journal:  Trends Genet       Date:  1995-10       Impact factor: 11.639

5.  Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors.

Authors:  T Pejovic; S Heim; N Mandahl; B Elmfors; U M Flodérus; S Furgyik; G Helm; H Willén; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1990-05       Impact factor: 5.006

6.  Tetrasomy 12 in ovarian tumors of thecoma-fibroma group: A fluorescence in situ hybridization analysis using paraffin sections.

Authors:  S B Liang; H Sonobe; T Taguchi; T Takeuchi; M Furihata; K Yuri; Y Ohtsuki
Journal:  Pathol Int       Date:  2001-01       Impact factor: 2.534

7.  Genomic aberrations in carcinomas of the uterine corpus.

Authors:  Francesca Micci; Manuel R Teixeira; Lisbeth Haugom; Gunnar Kristensen; Vera M Abeler; Sverre Heim
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

8.  Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors.

Authors:  V Shashi; W L Golden; C von Kap-Herr; W A Andersen; M J Gaffey
Journal:  Gynecol Oncol       Date:  1994-12       Impact factor: 5.482

9.  Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup.

Authors:  M Nilbert; S Heim; N Mandahl; U M Flodérus; H Willén; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1990-03

10.  Molecular cytogenetic characterization of tenosynovial giant cell tumors.

Authors:  Petter Brandal; Bodil Bjerkehagen; Sverre Heim
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more
  4 in total

1.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

2.  A novel truncated form of HMGA2 in tumors of the ovaries.

Authors:  Antonio Agostini; Ioannis Panagopoulos; Ben Davidson; Claes Goran Trope; Sverre Heim; Francesca Micci
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

3.  Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.

Authors:  Antonio Agostini; Marta Brunetti; Ben Davidson; Claes G Tropé; Sverre Heim; Ioannis Panagopoulos; Francesca Micci
Journal:  Oncotarget       Date:  2017-03-28

4.  Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.

Authors:  Sally M Hunter; Genevieve V Dall; Maria A Doyle; Richard Lupat; Jason Li; Prue Allan; Simone M Rowley; David Bowtell; Ian G Campbell; Kylie L Gorringe
Journal:  BMC Res Notes       Date:  2020-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.